Gurusankar Ramamoorthy

Title: Innovations by Gurusankar Ramamoorthy

Introduction

Gurusankar Ramamoorthy is an accomplished inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of cancer immunotherapy through his innovative research and patented inventions. His work focuses on developing novel compounds that target specific enzymes involved in cancer progression.

Latest Patents

Gurusankar holds a patent for "Substituted-3H-imidazo [4,5-c] pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics." This patent includes synthetic methods for creating these compounds, pharmaceutical compositions that incorporate them, and methods for treating disorders associated with ENPP1 dysfunction. He has 1 patent to his name.

Career Highlights

Throughout his career, Gurusankar has worked with notable organizations such as Stingray Therapeutics, Inc. and the University of Utah Research Foundation. His expertise in the field has allowed him to contribute to groundbreaking research and development in cancer treatment.

Collaborations

Gurusankar has collaborated with talented individuals like Hariprasad Vankayalapati and Xiaohui Liu. Their combined efforts have advanced the understanding and application of ENPP1 inhibitors in therapeutic settings.

Conclusion

Gurusankar Ramamoorthy's innovative work in cancer immunotherapy exemplifies the impact of dedicated research and invention. His contributions continue to pave the way for new treatment options in the fight against cancer.